— Know what they know.
Not Investment Advice

MANKIND.BO

Mankind Pharma Limited
1W: -2.3% 1M: -0.3% 3M: -11.1% YTD: -2.5% 1Y: -20.8%
₹2,038.40 ($21.65)
+18.15 (+0.90%)
 
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ₹834.0B · Alpha Radar Sell · Power 34
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹834.0B ($8.9B)
52W Range1967.9-2726.75
Volume408,997
Avg Volume21,391
Beta0.18
Dividend₹2.00
Analyst Ratings
No analyst coverage
Company Info
CEOSheetal Arora
Employees19,540
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2023-05-09
262, Okhla Industrial Estate
New Delhi 110 020
IN
91 11 4654 1111
About Mankind Pharma Limited

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms